Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Interleukin 4 and Interleukin 10 levels as pg/mL in non hodgkin lymphoma

Outcome Description:

We will measure 31 patients and 27 healthy person's Interleukin 4 and Interleukin 10 levels as pg/mL at the beginning of the study. We determined all of the patients IPI score, LDH (U/L), crp (mg/L), erythrocyte sedimentation rate, hemoglobin (gr/dL), lymphocyte count in per µL, albumin (gr/dL) before the treatment. We wanted to check whether there is any correlation between well known prognostic markers (LDH, crp, albumin, stage, ECOG performance status) and Interleukin-4 and interleukin-10 levels.

Outcome Time Frame:

This study ended within 13 months

Safety Issue:

No

Principal Investigator

Nil Guler, MD

Investigator Role:

Principal Investigator

Authority:

Turkey: Ondokuz Mayis local ethic committee

Study ID:

NG63900

NCT ID:

NCT01639716

Start Date:

May 2011

Completion Date:

June 2012

Related Keywords:

• Lymphoma
• Survey, interleukin status
• Lymphoma